Initiation of dosing in our Phase 1b clinical trial represents an important step in the clinical development of GT-02287 and in Gain’s mission to deliver a disease-modifying therapy to people with ...
24/7 Wall St. on MSN4d
Wall Street Predicts This Stock Will Gain 25% In 12 MonthsThor Industries (NYSE: THO) stock closed Monday trading below $100, but one analyst thinks it could be worth a lot more than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback